On May 28, the website of the Chinese Center for Disease Control and Prevention published the "General Information on Adverse Reaction Monitoring of COVID-19 Vaccine Vaccination" jointly published by the center and the National Adverse Drug Reaction Monitoring Center.

On May 11, BioPerfectus officially announced that their COVID-19 test kit for B.1.617 has been successfully developed.

Normally, it takes 10-15 years to develop a vaccine because of the complexity of vaccine development. The previous record was a mumps vaccine, which took four years to develop.

Recently, COVID-19 (SARS-CoV-2) Antigen Test Kit independently developed by Wuhan Easy Diagnosis passed the performance verification of Paul-Ehrlich-Institut in Germany.

At present, six new COVID-19 antigen (home-use) kits have been authorized for emergency use by BfArM. The certification means that the product can be sold in German supermarkets, and local residents can use the product for self-testing.

As of February 20, 2021, FDA has urgently authorized 14 COVID-19 antigen tests, involving 11 companies: Abbott、Ortho、Quidel 、BD、LumiraDx、Access Bio、Princeton BioMeditech、Luminostics、Celltrion、Quanterix、Ellume.

SARS-CoV-2 Inactivated Vaccine (Vero cells) developed by Beijing Sinovac Biotech Co., Ltd was approved for marketing with conditions.

On November 25, 2020（Beijing time）, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Innovita Biological ' novel coronavirus Innovita 2019-nCoV Ab Test (Colloidal gold).

On Aug 7th, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology.

From July to September, eight Chinese in vitro diagnostic companies have successively obtained Emergency Use Authorization(EUA) issued by US Food and Drug Administration (FDA) .